Clinical Trial Update: Phenolic Complex k110-42 Therapy on Cognitive Functions in Down Children [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Phenolic Complex k110-42 for cognitive function in children with Down syndrome; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Down Syndrome

Drugs mentioned

• Phenolic Complex k110-42

Snippet

Sponsor: Mansoura University | Conditions: Cognitive Functions | Phase 3 | Status: NOT_YET_RECRUITING